Concomitant Radiation and 5-Fluorouracil for Head and Neck Cancer

  • Bernard J. Cummings
  • Thomas J. Keane
  • A. Michael Rauth
Part of the Medical Radiology book series (MEDRAD)


One of the first trials of concomitant radiation and chemotherapy to show any improvement in survival rates included the administration of 5- fluorouracil (5-FU) during the course of radiation treatment of oral and oropharyngeal cancers (Lo et al. 1976). Nevertheless, while the premise that the cure rates for squamous cell cancers of the head and neck can be increased by the addition of chemotherapy to radiotherapeutic and surgical protocols is attractive, any clear demonstration of benefit from such combinations remains elusive. If a cytotoxic drug has demonstrable activity against the cancer being treated, combining such a drug with radiation might improve local control rates and reduce the incidence of distant metastases. If there is any synergistic interaction between the drug and radiation, a greater level of control might be achieved in tissues exposed to both agents than would result from the additive cytotoxic effects of the combination (Steel and Peckham 1979). However, if synergistic or additive effects also increase damage to normal tissues, the therapeutic ratio could be adversely affected by combined modality therapy. The many difficulties in interpreting the literature relating to laboratory studies and to clinical trials of combinations of radiation and cytotoxic drugs have been reviewed recently (Fu 1985; Iscoe 1987; Steel 1988; Tannock 1989).


Neck Cancer Cytotoxic Drug Radical Radiation Squamous Cell Cancer Intravenous Bolus Injection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adelstein DJ, Sharan VM, Earle AS et al. (1986) Chemor- adiotherapy as initial management in patients with squamous cell carcinoma of the head and neck. Cancer Treat Rep 70: 761–767PubMedGoogle Scholar
  2. Ansfield FJ, Ramirez G, Davis HL, Korbitz BC, Vermund H, Gollin FF (1970) Treatment of advanced cancer of the head and neck. Cancer 25: 78–82PubMedCrossRefGoogle Scholar
  3. Bolla M, Borgel J, Guenon A, Junien-Lavillauroy C, Dionet C, Vrousos C (1988) Chemotherapy with low doses of radiation followed by definitive radiotherapy for advanced unresectable carcinoma of the head and neck. NCI Monogr 6: 357–359PubMedGoogle Scholar
  4. Byfield JE, Calabro-Jones PM, Klisak I, Kulhanian F (1982) Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5- fluorouracil or ftorafur and x-rays. Int J Radiat Oncol Biol Phys 8: 1923–1933PubMedCrossRefGoogle Scholar
  5. Byfield JE, Sharp TR, Frankel SS, Tang SG, Callipari FB (1984) Phase I and II trial of five-day infused 5- fluorouracil and radiation in advanced cancer of the head and neck. J Clin Oncol 2: 406–413PubMedGoogle Scholar
  6. Carter SK (1977) The chemotherapy of head and neck cancer. Semin Oncol 4: 413–424PubMedGoogle Scholar
  7. Cummings BJ, Keane TJ, Harwood AR, Thomas GM (1986) Combined modality therapy with 5-fluorouracil, mitomycin C and radiation therapy for squamous cell cancer. In: Rosenthal CJ, Rotman M (eds) Clinical applications of continuous infusion chemotherapy and concomitant radiation therapy. Plenum, New York, pp 133–147CrossRefGoogle Scholar
  8. Dionet C, Rozan R, Achard JL et al. (1988) Sequential combination of 5-fluorouracil, cis-platinum and irradiation. 1. Advanced head and neck cancers. Radiother Oncol 11: 123–131Google Scholar
  9. Dobrowsky W, Dobrowsky E, Strassl H, Braun O, Scheiber V (1989) Response to preoperative concomitant radiochemotherapy with mitomycin C and 5-fluorouracil in advanced head and neck cancer. Eur J Cancer Clin Oncol 25: 845–849PubMedCrossRefGoogle Scholar
  10. Fletcher GH, Suit HD, Howe CD, Samuels M, Jesse RH, Villareal RU (1963) Clinical method of testing radiation- sensitizing agents in squamous cell carcinoma. Cancer 16: 355–363PubMedCrossRefGoogle Scholar
  11. Fletcher GH, Suit HD, Lindberg RD, Howe CD, Samuels ML, Jesse RH, Smith JP (1967) Chemotherapy as an adjuvant to surgery and radiation therapy. Proceedings 9th International Cancer Congress. UICC Monograph vol 10. Springer, Berlin Heidelberg New York, pp 177- 184Google Scholar
  12. Fu KK (1979) Normal tissue effects of combined radiotherapy and chemotherapy for head and neck cancer. Front Radiat Ther Oncol 13: 113–132Google Scholar
  13. Fu KK (1985) Biological basis for the interaction of che- motherapeutic agents and radiation therapy. Cancer 55: 2123–2130PubMedCrossRefGoogle Scholar
  14. Fu KK, Raynes BS, Lam KN (1984) Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion. Int J Radiat Oncol Biol Phys 10: 1473–1478CrossRefGoogle Scholar
  15. Goepfert H, Jesse RH, Lindberg RD (1973) Arterial infusion and radiation therapy in the treatment of advanced cancer of the nasal cavity and paranasal sinuses. Am J Surg 16: 464–468CrossRefGoogle Scholar
  16. Iscoe N (1987) Chemotherapy of head and neck cancer. Clin Oncol 5: 575–593Google Scholar
  17. Kaplan MJ, Hahn SS, Johns ME, Stewart FM, Constable WC, Cantrell RW (1985) Mitomycin and fluorouracil with concomitant radiotherapy in head and neck cancer. Arch Otolaryngol 111: 220–222PubMedCrossRefGoogle Scholar
  18. Keane TJ, Harwood AR, Beale FA, Cummings BJ, Payne DG, Rawlinson E (1985) A pilot study of mitomycin C and 5-fluorouracil infusion combined with split course radiation therapy for advanced carcinomas of the larynx and hypopharynx. J Otolaryngol 15: 286–288Google Scholar
  19. Komiyama S, Kudoh S, Yanagita, T, Kuwano M (1985) Synergistic combination therapy of 5-fluorouracil, vitamin A, and cobalt-60 radiation for head and neck tumors - antitumor combination therapy with Vitamin A. Auris Nasus Larynx 12 [Suppl II]: S239-S243PubMedGoogle Scholar
  20. Lo TCM, Wiley AL, Ansfield FJ et al. (1976) Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. AJR 126: 229–235PubMedGoogle Scholar
  21. Lokich JJ (1985) Optimal schedule for 5-fluorouracil chemotherapy. Am J Clin Oncol 8: 445–448PubMedCrossRefGoogle Scholar
  22. Maguire LC, Mendiondo OA, Medina WD, Cronin JD, Wheeler BM, Bartmas S (1987) Improved disease free survival in advanced head and neck carcinoma. Head and Neck Oncology Research. Kugler, Amsterdam, pp 271–274Google Scholar
  23. Marshall RS, Rauth AM (1988) Oxygen and exposure kinetics as factors influencing the cytotoxicity of por- firomycin, a mitomycin C analogue, in Chinese hamster ovary cells. Cancer Res 48: 5655–5659Google Scholar
  24. Marzecki Z, Krygier-Stojalowska A, Zaborek B, Mietkiewski J, Meyer A, Mazuryk R, Torbe Z (1980) Early clinical experience with radiation therapy of the advanced tumors following synchronization of the cell cycle with 5-fluorouracil. Radiobiol Radiother 21: 417–423Google Scholar
  25. Murthy AK, Taylor SG, Showel J et al. (1987) Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy. Int J Radiat Oncol Biol Phys 13: 1807–1813CrossRefGoogle Scholar
  26. Nitze HR, Vosteen KH, Ganzer U (1971) Radiation treatment of human tumors following the in vivo synchronization of the cell cycle. Acta Otolaryngol 71: 227–231PubMedCrossRefGoogle Scholar
  27. Overgaard J, Hjelm-Hanesen M, Vendelbo-Johansen L, Andersen AP (1988) Comparison of conventional and split course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 27: 147–152PubMedCrossRefGoogle Scholar
  28. Papac RJ (1984) Distant metastases from head and neck cancer. Cancer 53: 342–345PubMedCrossRefGoogle Scholar
  29. Pinedo HM, Peters GJ (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6: 1653–1664PubMedGoogle Scholar
  30. Rockwell S (1982) Cytotoxicities of mitomycin C and x-rays to aerobic and hypoxic cells in vitro. Int J Radiat Oncol Biol Phys 8: 1035–1039CrossRefGoogle Scholar
  31. Sato Y, Morita M, Takahashi H, Watanabe N, Kirikae I (1970) Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinuses. Cancer 25: 571–579PubMedCrossRefGoogle Scholar
  32. Sharp TR, Frankel SS, Byfield JE, Callipari F, Hornbeck CL (1983) Combined infusional 5-FU and x-ray therapy for advanced head and neck cancer - scheduling of radiosensitizing programs. Proc Am Soc Clin Oncol 2: 168Google Scholar
  33. Shigematsu Y, Sakai S, Fuchihata H (1971) Recent trials in the treatment of maxillary sinus carcinoma, with special reference to the chemical potentiation of radiation therapy. Acta Otolaryngol 71: 63–70PubMedCrossRefGoogle Scholar
  34. Smith BL, Franz JL, Mira JG, Gates GA, Sapp J, Cruz AB (1980) Simultaneous combination radiotherapy and multidrug chemotherapy for stage III and stage IV squamous cell carcinoma of the head and neck. J Surg Oncol 15: 91–98PubMedCrossRefGoogle Scholar
  35. Steel GG (1988) The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 11: 31–53PubMedCrossRefGoogle Scholar
  36. Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5: 85–91PubMedGoogle Scholar
  37. Tannock IF (1989) Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 16: 83–101PubMedCrossRefGoogle Scholar
  38. Tsujii H, Kamada T, Arimoto T, Mizoe J, Shirato H, Matsuoka Y, Irie G (1986) The role of radiotherapy in the management of maxillary sinus carcinoma. Cancer 57: 2261–2266PubMedCrossRefGoogle Scholar
  39. Valeriote F, Santelli G (1984) 5-Fluorouracil (FUra). Pharmacol Ther 24: 107–132PubMedCrossRefGoogle Scholar
  40. Van Putten LM, Kram LK, van Dierendonck HH, Smink T, Fuzy M (1975) Enhancement by drugs of metastatic lung nodule formation after intravenous tumor cell injection. Int J Cancer 15: 588–595PubMedCrossRefGoogle Scholar
  41. Verweij J, Stuurman M, De Vries J, Pinedo HM (1986) The difference in pharmacokinetics of mitomycin C, given either as a single agent or as part of a combination chemotherapy. J Cancer Res Clinic Oncol 112: 283– 285CrossRefGoogle Scholar
  42. von der Maase H, Overgaard J, Vaeth M (1986) Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 5: 245–257PubMedCrossRefGoogle Scholar
  43. Weinberg MJ, Rauth AM (1987) 5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys 13: 1691–1699PubMedCrossRefGoogle Scholar
  44. Wendt TG, Wustrow TPU, Hartenstein RC, Rohloff R, Trott KR (1987) Accelerated split-course radiotherapy and simultaneous cis-dichlorodiammine-platinum and 5- fluorouracil chemotherapy with folinic acid enhancement for unresectable carcinoma of the head and neck. Radiother Oncol 10: 277–284PubMedCrossRefGoogle Scholar
  45. Will CH, Hering KG, Dieckmann J (1983) Combination of 5-fluorouracil and Co-60 irradiation in the treatment of carcinoma of the oro-facial region. Int J Oral Surg 12: 141–146PubMedCrossRefGoogle Scholar
  46. Withers HR, Taylor JMG, Maciejewski B (1988) The hazard of accelerated tumor donogen repopulation during radiotherapy. Acta Oncol 27: 131–146PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Bernard J. Cummings
    • 1
  • Thomas J. Keane
    • 1
  • A. Michael Rauth
    • 2
  1. 1.Department of Radiation OncologyOntario Cancer InstituteTorontoCanada
  2. 2.Division of PhysicsOntario Cancer InstituteTorontoCanada

Personalised recommendations